Detalhe da pesquisa
1.
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
BMC Cancer
; 16: 270, 2016 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27068103
2.
Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization.
Gastric Cancer
; 17(4): 638-47, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24414131
3.
Biomarkers for antitumor activity of bevacizumab in gastric cancer models.
BMC Cancer
; 12: 37, 2012 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22273502
4.
Bevacizumab improves the delivery and efficacy of paclitaxel.
Anticancer Drugs
; 21(7): 687-94, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20559127
5.
Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models.
Oncol Rep
; 22(2): 241-7, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19578762
6.
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro.
TH Open
; 2(1): e96-e103, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249933
7.
Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models.
Cancer Chemother Pharmacol
; 59(6): 795-805, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17031648
8.
Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.
Cancer Chemother Pharmacol
; 59(6): 807-15, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17009035
9.
Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
Oncol Rep
; 14(3): 695-9, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16077977
10.
1α,25(OH)2D3 downregulates gene expression levels of muscle ubiquitin ligases MAFbx and MuRF1 in human myotubes.
Biomed Res
; 36(2): 71-80, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25876656
11.
Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.
Mol Cancer Ther
; 14(2): 533-41, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25522765
12.
Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5'-dFUrd in human breast cancer models.
Cancer Chemother Pharmacol
; 49(3): 211-6, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11935213
13.
Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells.
Lung Cancer
; 83(1): 44-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192512
14.
Melting curve analysis for mutations of EGFR and KRAS.
Anticancer Res
; 34(2): 613-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510990
15.
Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model.
Oncol Rep
; 30(3): 1087-93, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23783223
16.
Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts.
Oncol Rep
; 27(4): 923-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22209766
17.
Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models.
Clin Cancer Res
; 17(15): 5060-70, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21700765
18.
Effect of erythropoietin on human tumor growth in xenograft models.
Mol Med Rep
; 3(1): 95-101, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21472206
19.
Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.
Cancer Chemother Pharmacol
; 66(2): 269-76, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19904537
20.
Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells.
Biomed Res
; 30(1): 47-51, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19265263